Chimerix Results Presentation Deck
March 2022, 12 slides
  1. Chimerix
  2. Related Decks
  3. Results Presentation Decks
the nucleoside antiviral inhibits in human airway epithelial cell cultures and exhibits prophylactic and therapeutic efficacy against respiratory disease in a mouse model of infection march | Chimerix
forward looking statements | Chimerix
novel outbreaks occurring every years what next | Chimerix
direct acting antiviral delivered to key site of viral replication to enhance efficacy and safety for | Chimerix
oral formulation developed through phase study | Chimerix
the active site is highly conserved cove a a a a a a lid a | Chimerix
in activity against bat | Chimerix
collaboration with employed a preclinical model | Chimerix
treatment initiated post infection significantly improved titers and lung pathology at day | Chimerix
treatment post infection protected mice from body weight loss and clinical symptoms of disease | Chimerix
potential for rapid bridging program to drive to with inhaled formulation pharmacology selection optimization | Chimerix
major scientific contributors to effort on baxter taft knight bekah mark foster ware | Chimerix
See More
Chimerix
Results Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Lung
Plasma
Recent decks by Chimerix
Investor Presentation
August 2023
Investor Presentation
May 2023
Investor Presentation
March 2023
Investor Conference
November 2021
See all presentations by Chimerix (6 decks)
Related decks
Genprex
Investor Presentation
October 2022
Genelux
Investor Presentation
December 2023
Genelux
Investor Presentation
February 2024
Minerva
IPO
October 2021
Kymera
Investor Presentation
June 2023
AstraZeneca
Investor Event
September 2024
Genelux
Investor Presentation
July 2023
AstraZeneca
Investor Event
June 2023
Recent decks by Chimerix
See all presentations (6 decks)
Investor Presentation
August 2023
Investor Presentation
May 2023
Investor Presentation
March 2023
Investor Conference
November 2021
Genprex
Investor Presentation
October 2022
Genelux
Investor Presentation
December 2023
Genelux
Investor Presentation
February 2024
Minerva
IPO
October 2021
Kymera
Investor Presentation
June 2023
AstraZeneca
Investor Event
September 2024
Genelux
Investor Presentation
July 2023
AstraZeneca
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights